CRP and cancer: C-reactive protein (CRP), as a most sensitive inflammatory biomarker, has been confirmed in a series of cancers to predict the prognosis, including patients with EC (Shimada et al., 2003; Nozoe, Saeki & Sugimachi, 2001; Platt et al., 2012).